By Dr Dorothy Ann Machalek

Preprints

Machalek DA; Traeger MW; Vodstrcil LA; Aung E; Asselin J; Stoove M; Murray GL; Garland SM; Plummer E; Fairley CK; McNulty A; Menon A; Bell C; Thng C; Lewis DA; Guy R; Bradshaw C, 2026, Trends in Mycoplasma genitalium Testing, Positivity and Macrolide Resistance in Australia, 2014–2024: A Retrospective Sentinel Surveillance Study, http://dx.doi.org/10.2139/ssrn.6291473

Scorgie F; Makhale L; Chikandiwa A; Tshandu P; Rees H; Khoza N; Machalek DA; Kaldor JM; Delany-Moretlwe S, 2026, Vaccine Acceptance and Hesitancy in a Single-Dose HPV Vaccination Campaign in South Africa: A Qualitative Study Among Diverse Stakeholders, http://dx.doi.org/10.2139/ssrn.6041640

Gandelin M; Tran PL; Chirpaz E; Jaffar-Bandjee M-C; Traversier N; Machalek D; Bertolotti A, 2023, Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study (Preprint), http://dx.doi.org/10.2196/preprints.47379

Machalek DA; Vette KM; Downes M; Carlin JB; Nicholson S; Hirani R; Irving DO; Gosbell IB; Gidding HF; Shilling H; Aung E; Macartney K; Kaldor JM, SEROLOGICAL TESTING OF BLOOD DONORS TO CHARACTERISE THE IMPACT OF COVID-19 IN MELBOURNE, AUSTRALIA, 2020, http://dx.doi.org/10.1101/2022.03.11.22272185

Bavor C; Brotherton JM; Smith MA; Prang K-H; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE, The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study, http://dx.doi.org/10.21203/rs.3.rs-3012586/v1

Back to profile page